GENEVA, July 2 -- TENVIE THERAPEUTICS, INC. filed a patent application (US2025/060280) for “MODULATORS OF NLR FAMILY PYRIN DOMAIN CONTAINING 3 AND METHODS ASSOCIATED THEREWITH”. With publication no. WO/2026/136648, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 253/07

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....